Research Report on China's Ophthalmic Preparation Industry 2011-2012
In China, ophthalmic diseases mainly include cataract, glaucoma, ocular inflammations, xeroma, ocular fundus diseases, ocular trauma, PCO (posterior capsule opacification), etc., among which cataract and glaucoma rank the first two in terms of prevalence of ophthalmic diseases.
In China, ophthalmic preparations are mainly divided in such five categories as pharmaceutical chemicals, Chinese patent medicines, health products, disinfection sterilization products and apparatus.
In 2010, China's ophthalmic preparation market realized about CNY 6.90 billion, increasing by about 8.20% YOY.
After years of development, China's retail market of ophthalmic products has formed such five medicine categories as visual fatigue relieving medicines, anti-inflammatory medicines, cataract relieving medicines, pseudo myopia medicines and anti-glaucoma medicines, among which visual fatigue relieving medicines occupy the largest market share of over 30%; anti-inflammatory medicines are closely followed, accounting for about 30% of the market share; cataract medicines and pseudo myopia medicines occupy over 10% of the market share while anti-glaucoma medicines occupy a relatively small share of only 1%.
It can be found from the research on sales of the ophthalmic preparation market by preparation formulations that eye drops occupy the largest market share, reaching over 80% of the whole ophthalmic preparation market. In fact, convenience and quick results of eye drops are favored by consumers, and most consumers have formed the preference for eye drop preparation formulation. This situation will not change in the short run. Therefore, the leading position of eye drop preparation will be firm and stable in the market.
In China's ophthalmic preparation market, Shandong Chia Tai Freda Pharmaceutical and Mentholatum (Zhongshan) Pharmaceutical Co., Ltd. rank among the first group. Japan Santen Pharmaceutical Co., Ltd. and Jiangxi Tianshikang Traditional Chinese Medicine Co., Ltd. rank among the second group.
With gradual aging of the Chinese population, intensified environmental pollution and popularity of computers, the incidence of ophthalmic diseases in China keeps rising. It is predicted that in the next few years, China's annual growth rate of the ophthalmic market will remain above 8%.
As for ophthalmic preparation manufacturers, the status of Chinese market will become increasingly important.
More following information can be acquired from this report:
Following are suggested to buy this report:
In China, ophthalmic preparations are mainly divided in such five categories as pharmaceutical chemicals, Chinese patent medicines, health products, disinfection sterilization products and apparatus.
In 2010, China's ophthalmic preparation market realized about CNY 6.90 billion, increasing by about 8.20% YOY.
After years of development, China's retail market of ophthalmic products has formed such five medicine categories as visual fatigue relieving medicines, anti-inflammatory medicines, cataract relieving medicines, pseudo myopia medicines and anti-glaucoma medicines, among which visual fatigue relieving medicines occupy the largest market share of over 30%; anti-inflammatory medicines are closely followed, accounting for about 30% of the market share; cataract medicines and pseudo myopia medicines occupy over 10% of the market share while anti-glaucoma medicines occupy a relatively small share of only 1%.
It can be found from the research on sales of the ophthalmic preparation market by preparation formulations that eye drops occupy the largest market share, reaching over 80% of the whole ophthalmic preparation market. In fact, convenience and quick results of eye drops are favored by consumers, and most consumers have formed the preference for eye drop preparation formulation. This situation will not change in the short run. Therefore, the leading position of eye drop preparation will be firm and stable in the market.
In China's ophthalmic preparation market, Shandong Chia Tai Freda Pharmaceutical and Mentholatum (Zhongshan) Pharmaceutical Co., Ltd. rank among the first group. Japan Santen Pharmaceutical Co., Ltd. and Jiangxi Tianshikang Traditional Chinese Medicine Co., Ltd. rank among the second group.
With gradual aging of the Chinese population, intensified environmental pollution and popularity of computers, the incidence of ophthalmic diseases in China keeps rising. It is predicted that in the next few years, China's annual growth rate of the ophthalmic market will remain above 8%.
As for ophthalmic preparation manufacturers, the status of Chinese market will become increasingly important.
More following information can be acquired from this report:
- Status of China's Ophthalmic Preparation Market
- Competition in China's Ophthalmic Preparation Market
- China's Major Ophthalmic Preparation Manufacturers
- Development Trend of China's Ophthalmic Preparation Industry
Following are suggested to buy this report:
- Ophthalmic Preparation Manufacturers
- Ophthalmic Preparation Trading Enterprises
- Investors Focusing on Ophthalmic Preparation Industry
- Investors Focusing on Ophthalmic Preparation Industry
1 OPHTHALMIC PREPARATION OVERVIEW
1.1 Ophthalmic Disease Overview
1.1.1 Cataract
1.1.2 Glaucoma
1.1.3 Ocular Inflammations
1.1.4 Xeroma
1.1.5 Ocular Fundus Diseases
1.2 Incidence of Ophthalmic Diseases in China
2 STATUS OF CHINA'S OPHTHALMIC PREPARATION MARKET, 2009-2010
2.1 Analysis on China's Ophthalmic Preparation Market
2.2 Analysis on China's Ophthalmic Preparation Market Shares
2.3 Analysis on Market Shares of Ophthalmic Preparation Manufacturers
2.4 Growth Rates of China's Major Ophthalmic Preparation Varieties, 2009-2010
3 ANALYSIS ON CHINA'S MAJOR OPHTHALMIC PREPARATIONS, 2009-2010
3.1 Ofloxacin
3.2 Levofloxacin
3.3 Sodium Hyaluronate
3.4 Tobramycin/Dexamethasone
3.5 Tobramycin Sulfate
3.6 Basic Fibroblast Growth Factor
3.7 Pranoprofen
3.8 Difrarel
4 ANALYSIS ON CHINA'S MAJOR OPHTHALMIC PREPARATION MANUFACTURERS, 2010-2011
4.1 Hubei Qianjiang Pharmaceutical Co., Ltd.
4.2 Mentholatum (China) Pharmaceutical Co., Ltd.
4.3 Shandong Chia Tai Freda Pharmaceutical Co., Ltd.
4.4 Japan Santen Pharmaceutical Co., Ltd.
4.5 Jiangxi Tianshikang Traditional Chinese Medicine Co., Ltd.
4.6 Shandong Bausch & Lomb Freda Pharmaceutical Co., Ltd.
4.7 Traditional Chinese Medicine Factory of Hangzhou Tianmushan Pharmaceutical Enterprises Co., Ltd.
4.8 Fujian Shemingzhu Eye Drop Co., Ltd.
4.9 Shenyang Xingqi Pharmaceutical Co., Ltd.
4.10 Tianjin Wanjia Pharmaceutical Co., Ltd.
4.11 Hebei Jinniu Pharmaceutical Co., Ltd.
4.12 Changchun Dirui Pharmaceutical Co., Ltd.
5 PREDICTION ON CHINA'S OPHTHALMIC PREPARATION MARKET SCALE, 2011-2015
5.1 Analysis on Factors Influencing Development
5.2 Market Scale Prediction
5.3 Development Recommendations
1.1 Ophthalmic Disease Overview
1.1.1 Cataract
1.1.2 Glaucoma
1.1.3 Ocular Inflammations
1.1.4 Xeroma
1.1.5 Ocular Fundus Diseases
1.2 Incidence of Ophthalmic Diseases in China
2 STATUS OF CHINA'S OPHTHALMIC PREPARATION MARKET, 2009-2010
2.1 Analysis on China's Ophthalmic Preparation Market
2.2 Analysis on China's Ophthalmic Preparation Market Shares
2.3 Analysis on Market Shares of Ophthalmic Preparation Manufacturers
2.4 Growth Rates of China's Major Ophthalmic Preparation Varieties, 2009-2010
3 ANALYSIS ON CHINA'S MAJOR OPHTHALMIC PREPARATIONS, 2009-2010
3.1 Ofloxacin
3.2 Levofloxacin
3.3 Sodium Hyaluronate
3.4 Tobramycin/Dexamethasone
3.5 Tobramycin Sulfate
3.6 Basic Fibroblast Growth Factor
3.7 Pranoprofen
3.8 Difrarel
4 ANALYSIS ON CHINA'S MAJOR OPHTHALMIC PREPARATION MANUFACTURERS, 2010-2011
4.1 Hubei Qianjiang Pharmaceutical Co., Ltd.
4.2 Mentholatum (China) Pharmaceutical Co., Ltd.
4.3 Shandong Chia Tai Freda Pharmaceutical Co., Ltd.
4.4 Japan Santen Pharmaceutical Co., Ltd.
4.5 Jiangxi Tianshikang Traditional Chinese Medicine Co., Ltd.
4.6 Shandong Bausch & Lomb Freda Pharmaceutical Co., Ltd.
4.7 Traditional Chinese Medicine Factory of Hangzhou Tianmushan Pharmaceutical Enterprises Co., Ltd.
4.8 Fujian Shemingzhu Eye Drop Co., Ltd.
4.9 Shenyang Xingqi Pharmaceutical Co., Ltd.
4.10 Tianjin Wanjia Pharmaceutical Co., Ltd.
4.11 Hebei Jinniu Pharmaceutical Co., Ltd.
4.12 Changchun Dirui Pharmaceutical Co., Ltd.
5 PREDICTION ON CHINA'S OPHTHALMIC PREPARATION MARKET SCALE, 2011-2015
5.1 Analysis on Factors Influencing Development
5.2 Market Scale Prediction
5.3 Development Recommendations
SELECTED CHARTS
Chart China's Ophthalmic Preparation Market Scale, 2006-2010
Chart Changes in Market Shares of China's Major Ophthalmic Preparation Varieties, 2007-2009
Chart China's Ophthalmic Preparation Enterprises with Top 20 Market Shares, 2007-2009
Chart Ofloxacin Market Competition Pattern in China
Chart Levofloxacin Market Competition Pattern in China
Chart Hyaluronate Sodium Market Competition Pattern in China
Chart Prediction on China's Ophthalmic Preparation Market Scale, 2011-2015
Chart China's Ophthalmic Preparation Market Scale, 2006-2010
Chart Changes in Market Shares of China's Major Ophthalmic Preparation Varieties, 2007-2009
Chart China's Ophthalmic Preparation Enterprises with Top 20 Market Shares, 2007-2009
Chart Ofloxacin Market Competition Pattern in China
Chart Levofloxacin Market Competition Pattern in China
Chart Hyaluronate Sodium Market Competition Pattern in China
Chart Prediction on China's Ophthalmic Preparation Market Scale, 2011-2015
